Table 1.
A summary of the main findings of neuroimaging studies in chronic migraine patients.
Study | Study cohorts | Main findings | Potential confounders |
---|---|---|---|
RESTING STATE fMRI STUDIES | |||
Androulakis et al. (14, 15) | 13 CM patients without MOH (all females), 16 CM patients with MOH (all females) vs. 19 controls (all females) |
|
|
Chen et al. (16) | 16 CM patients without MOH, 18 EM patients vs. 21 controls |
|
|
Coppola et al. (17) | 20 CM patients without MOH vs. 20 controls |
|
|
Lee et al. (18) | 19 CM patients without MOH vs. 45 EM patients |
|
|
Lerebours et al. (19) | 25 CM patients with MOH vs. 22 EM patients |
|
|
Schwedt et al. (20) | 20 CM patients without MOH vs. 20 controls |
|
|
fMRI STUDIES OF NOCICEPTIVE STIMULATION | |||
Ferraro et al. (21) | 9 CM patients with MOH (all females) vs. 9 controls (all females) |
|
|
Schulte et al. (22) | 17 CM patients without MOH, 18 EM patients vs. 19 controls |
|
|
fMRI STUDIES DURING A DECISION-MAKING TASK | |||
Ferraro et al. (23) | 8 CM patients with MOH (all females), 8 detoxified CM patients with MOH (all females), 8 CM patients without MOH (all females) vs. 8 controls (all females) |
|
|
fMRI STUDIES OF VISUAL STIMULATION | |||
Schulte et al. (24) | 17 CM patients without MOH, 18 EM patients vs. 19 controls |
|
|
POSITRON EMISSION TOMOGRAPHY STUDIES | |||
Aurora et al. (25) | 10 CM patients with or without MOH |
|
|
Fumal et al. (26) | 16 CM patients with MOH vs. 68 controls |
|
|
Matharu et al. (27) | 8 CM patients |
|
|
PROTON MAGNETIC RESONANCE SPECTROSCOPY STUDIES | |||
Niddam et al. (28) | 25 CM patients without MOH, 24 EM patients vs. 25 controls |
|
|
MORPHOMETRIC STUDIES | |||
Bilgic et al. (29) | 17 CM patients without MOH (all females), 7 CM patients with MOH (all females) vs. 24 controls (all females) |
|
|
Chen et al. (16) | 16 CM patients without MOH, 18 EM patients vs. 21 controls |
|
|
Coppola et al. (30) | 20 CM patients without MOH vs. 20 controls |
|
|
Hubbard et al. (31) | 23 CM patients (11 responders and 12 non-responders to prophylactic treatment with onabotulinumtoxinA) |
|
|
Lai et al. (32) | 33 CM patients with MOH (19 responders to common preventive treatments), 33 CM patients without MOH vs. 33 controls |
|
|
Liu et al. (33) | 39 CM patients, 83 EM patients (15 patients with MOH) vs. 31 controls |
|
|
Neeb et al. (34) | 6 CM patients without MOH, 15 CM patients with MOH, 21 EM patients vs. 21 controls |
|
|
Niddam et al. (28) | 25 CM patients without MOH, 24 EM patients vs. 25 controls |
|
|
Riederer et al. (35) | 31 CM patients with MOH (10 responders and 8 non-responders to medication withdrawal) |
|
|
Schwedt et al. (36) | 15 CM patients without MOH, 51 EM patients vs. 54 controls |
|
CM, chronic migraine; DAS, dorsal attention system; DMN, default mode network; EM, episodic migraine; ECN, executive control network; fMRI, functional magnetic resonance imaging; MOH, medication overuse headache; RS FC, resting state functional connectivity; SN, salience network.